Abstract
Background Recent epidemics and measures taken to control them – through vaccination or other actions – have highlighted the role and importance of uncertainty in public health. There is generally a trade-off between information collection and other uses of resources. Explicitly or more implicitly, the concept of expected value of perfect information (EVPI) is central in order to inform policy makers in an uncertain environment.
Method We use a simple SIR disease emergence and transmission model with vaccination that can be administered as one or two doses. The disease parameters and vaccine characteristics are uncertain. We study the trade-offs between information acquisition and two other measures: bringing vaccination forward, and acquiring more vaccine doses. To do this, we quantify the EVPI under different constraints faced by public health authorities, i.e. the time of the vaccination campaign implementation and the number of vaccine doses available.
Results We discuss the appropriateness of different responses under uncertainty. We show that in some cases, vaccinating later or with less vaccine doses but more information may bring better results than vaccinating earlier or with more doses and less information respectively.
Conclusion In the present methodological paper, we show in an abstract setting how clearly defining and treating the trade-off between information acquisition and the relaxation of constraints can improve public health decision making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: houy{at}gate.cnrs.fr.
Data Availability
All data produced in the present study are available upon reasonable request to the authors